Understanding Chemotherapy: What Does Carmustine Do?
•
4 min read
In a retrospective study of 85 newly diagnosed glioblastoma multiforme (GBM) patients, the cohort receiving carmustine wafers had a 2-year survival rate of 47%, compared to 29% for the non-carmustine cohort [1.14.1]. So, **what does carmustine do** to achieve these results? It is a powerful chemotherapy drug used to treat several types of cancer.
